Cerebrospinal fluid inositol monophosphatase: Elevated activity in depression and neuroleptic-treated schizophrenia

Biological Psychiatry

Volumn 44, Issue 6, 1998, Pages 433-437

  Atack, John R ^a   Levine, Joseph ^b   Belmaker, Robert H ^b  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Cerebrospinal fluid; Depression; Inositol; Inositol monophosphatase; Lithium; Phosphatidyl inositol; Schizophrenia

Indexed keywords

INOSITOL; INOSITOL MONOPHOSPHATASE; INOSITOL PHOSPHATE; LITHIUM; NEUROLEPTIC AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; ENZYME REGULATION; HEADACHE; HUMAN; HUMAN TISSUE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA; SIGNAL PROCESSING;

ANTIPSYCHOTIC AGENTS; DEPRESSIVE DISORDER; FEMALE; HUMANS; LITHIUM; MALE; MIDDLE AGED; PHOSPHORIC MONOESTER HYDROLASES; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

EID: 0032530235     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00065-1     Document Type: Article

References (22)

1. Agam G., Livne A. Inositol-1-phosphatase of human erythrocytes is inhibited by therapeutic lithium concentrations. Psychiatry Res. 27:1989;217-224.
2. Agam G., Shapiro J., Levine J., Stier S., Schields C., Bersudsky Y., et al. Short-term lithium treatment does not reduce human CSF inositol levels. Lithium. 4:1993;267-269.
3. Atack J.R. Inositol monophosphatase, the putative therapeutic target for lithium. Brain Res Rev. 22:1996;183-190.
4. Atack J.R., Rapoport S.I., Varley C.L. Characterization of inositol monophosphatase in human cerebrospinal fluid. Brain Res. 613:1993;305-308.
5. Barkai A.I., Dunner D.L., Gross H.A., Mayo P., Fieve R.R. Reduced myo-inositol levels in cerebrospinal fluid from patients with affective disorder. Biol Psychiatry. 13:1978;65-72.
6. Belmaker R.H., Stein D., Weinberger D., Potkin S.G., Wyatt R.J. Cerebrospinal fluid cyclic nucleotides in schizophrenia. Usdin E., Carlsson A., Dahlstrom A., Engel J. Catecholamines Neuropharmacology and Central Nervous System Therapeutic Aspects . 1984;173-178 Liss, New York.
7. Belmaker R.H., Bersudsky Y., Agam G., Levine J., Kofman O. How does lithium work on manic depression? Clinical and psychological correlates of the inositol theory. Annu Rev Med. 47:1996;47-56.
8. Berridge M.J. Inositol trisphosphate and calcium signalling. Nature. 361:1993;315-325.
9. Berridge M.J., Downes C.P., Hanley M.R. Neural and developmental actions of lithium A unifying hypothesis . Cell. 59:1989;411-419.
10. Fisher S.K., Heacock A.M., Agranoff B.W. Inositol lipids and signal transduction in the nervous system An update . J Neurochem. 58:1992;18-38.
11. Hallcher L.M., Sherman W.R. The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J Biol Chem. 255:1980;10896-10901.
12. Hudson C.J., Young L.T., Li P.P., Warsh J.J. CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia. Synapse. 13:1993;278-293.
13. Levine J., Gonzalves M., Barbur I., Stir S., Elizur A., Kofman O., et al. Inositol 6 gm daily may be effective in depression but not in schizophrenia. Hum Psychopharmacol. 8:1993;49-53.
14. Levine J., Rapaport A., Lev L., Bersudsky Y., Kofman O., Belmaker R.H., et al. Inositol treatment raises CSF inositol levels. Brain Res. 627:1993;168-170.
15. Levine J., Goldberger I., Rapaport A., Schwartz M., Schields C., Elizur A., et al. CSF inositol levels in schizophrenia and high-dose inositol treatment of schizophrenia. Eur Neuropsychopharmacol. 4:1994;487-490.
16. Levine J., Barak Y., Gonzalves M., Szor H., Elizur A., Kofman O., et al. Double-blind, controlled trial of inositol treatment of depression. Am J Psychiatry. 152:1995;792-794.
17. Levine J., Kurtzman L., Rapoport A., Zimmerman J., Bersudsky Y., Shapiro J., et al. CSF inositol does not predict antidepressant response to inositol. J Neural Transm. 103:1996;1457-1462.
18. Milhorat T.H., Hammock M.K. Cerebrospinal fluid as reflection of internal milieu of brain. Wood J.H. Neurobiology of Cerebrospinal Fluid, vol 2. 1983;1-23 Plenum Press, New York.
19. Molchan S.E., Atack J.R., Sunderland T. Decreased CSF inositol monophosphatase activity after lithium treatment. Psychiatry Res. 53:1994;103-105.
20. Moscovich D.G., Belmaker R.H., Agam G., Livne A. Inositol-1-phosphatase in red blood cells of manic-depressive patients before and during treatment with lithium. Biol Psychiatry. 27:1990;552-555.
21. Nemanov L, Ebstein RP, Osher Y, Belmaker RH, Agam G (in submission): Effect of bipolar disorder and lithium treatment on lymphocyte inositol monophosphatase relative mRNA levels.
22. Zilberman-Kaufman M., Agam G., Moscowits L., Livne A.A., Belmaker R.H. Raised monophosphatase activity in schizophrenic patients. Clin Chim Acta. 209:1992;89-93.